Halk Sağlığı İçin Ciddi Bir Tehdit: Sosyal Medyada Tıbbi Bitki Reklamları Sosyal Medyada Tıbbi Bitkiler

İmran Altıokka; Afife Mat

doi:10.26650/JARHS2021-752686

Review

A Serious Threat to Public Health: Medicinal Plant Publicities in Social Media Medicinal Plants in Social Media

Year 2021, Volume: 4 Issue: 1, 40 - 48, 10.02.2021

İmran Altıokka Afife Mat

https://doi.org/10.26650/JARHS2021-752686

Abstract

The accuracy of information on social media about widely used medicinal and aromatic plants was assessed scientifically. The three most popular medicinal plants were selected and how they were presented and the advice given about their use on social media were analyzed. As there is a lack of any regulations or filtering of information, misinformation on the internet was found to be a threat to the public health. It has been thought that a control mechanism has to be set by the health authorities in order to protect the people who are using these plants according to the unreliable information on the internet.

Keywords

Social media, Hypericum perforatum, Panax ginseng, Curcuma longa, drug-plant interactions, misuse of medicinal plants

References

1. Tavlı ÖF, Hazman Ö, Büyükben A, Yılmaz FN, Özbek Çelik B, Eroğlu Özkan E. İstanbul Aktarlarında satılan Hypericum perforatum örneklerinin farmakognozik açıdan incelenmesi, Ankara Ecz Fak Der 2020;44(2):265-80.
2. Kuruldak E. Curcumae longae rhizoma drogunun tedavi değeri ve kalite kontrolü, Bitirme Projesi, İstanbul Üniversitesi Eczacılık Fakültesi, Farmakognozi Anabilim Dalı, Danışman: Afife Mat. 2019, 38.
3. Bombardelli E, Morazzoni P. Hypericum perforatum. Fitoterapia (Milano), 1995;66(1):43- 68.
4. Baytop T. Türkiye’de bitkiler ile tedavi (geçmişte ve bugün) Nobel Tıp Kitabevi, İstanbul; 1984:166-7.
5. Bone K, Mills S. Principles of herbal pharmacology. Principles and Practice of Phytotherapy: Modern Herbal Medicine; Churchill Livingstone: New York, NY,USA,2013;1056.
6. Barnes J, Anderson LA, Phillipson JD. St John’s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2001;53(5):583-600.
7. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett, P. St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 2002;54(4);349-56.
8. Suzuki O,Katsumata Y,Oya M, Bladt S,Wagner H. Inhibition of monoamine oxidase by hypericin. Planta Med 1984;50(3):272–4.
9. Mennini T, Gobbi M. The antidepressant mechanism of Hypericum perforatum. Life sciences 2004;75(9):1021-7.
10. Ersoy E, Eroğlu Özkan E, Mat A. Yeni çalışmalar ışığında Hypericum türlerinin farmakolojik aktiviteleri, Sağlık Bilimlerinde İleri Araştırmalar Dergisi 2019;2(2):71-9.
11. Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St. John’s wort (Hypericum perforatum L.). Eur J Clin Pharmacol 1998;54(8):589-94.
12. Escop, European Scientific Cooperative on Phytotherapy. The scientific foundation for herbal medicinal products. ESCOP Monographs:2 nd edition Edition second 2003;211: 257.
13. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John’s wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66(4):338-45.
14. Kiefer DS, Pantuso T. Panax ginseng. Am Fam Physician 2003;68(8):1539-42.
15. Schulz V, Hänsel R, Blumenthal M, Tyler VE. Rational phytotherapy: A reference guide for physicians and pharmacists., Springer Science & Business Media. Verlag Berlin Heildelberg,Printed in Germany 2004; 373.
16. Li H, Kang T, Qi B, Kong L, Jiao Y, Cao Y. et al. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer’s disease. J Ethnopharmacol 2016;179:162-9.
17. Kim HJ, Jung SW, Kim SY, Cho IH, Kim HC. et al. Panax ginseng as an adjuvant treatment for Alzheimer’s disease. J Ginseng Res 2018;42(4):401-11.
18. Liu F, Xuan NX, Ying SM, Li W, Chen ZH, Shen HH. Herbal medicines for asthmatic inflammation: from basic researches to clinical applications. Mediato Inflamm 2016:6943135.
19. Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 2014; 32(6):1053-64.
20. Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Invest Drugs 2004;13(10):1327-38.
21. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Ann Indian Acad Neurol 2008;11(1):13.
22. B Mythri R, M Srinivas Bharath M. Curcumin: a potential neuroprotective agent in Parkinson’s disease. Current Pharm Des 2012;18(1):91-9.
23. Xie L, Li XK, Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol 2011;11(3):323-30.
24. Kurup VP, Barrios CS. Immunomodulatory effects of curcumin in allergy. Mol Nutr Food Res 2008;52(9):1031-9.
25. Daveluy A, Géniaux H, Thibaud L, Mallaret M, Miremont-Salamé G, Haramburu F. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).Therapie 2014;69(6):519-20.
26. Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J Ethnopharmacol 2017; 209:1-12.
27. Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, Gelfand JM. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J Am Acad Dermatol 2008;58(4):625-31.
28. D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005;55(5):319-21.
29. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski R. Z. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer research 2002;62(13):3868-75.